Genotoxic activities of aniline and its metabolites and their relationship to the carcinogenicity of aniline in the spleen of rats

Critical Reviews in Toxicology

Volumn 35, Issue 10, 2005, Pages 783-835

  Bomhard, Ernst M ^a,b   Herbold, Bernd A ^a  

^a BAYER PHARMA AG   (Germany)

^b NONE   (Germany)

Author keywords

Aniline; Clastogenic Activity; Mouse Lymphoma Tests; Primary Genetic Activity; Rats; Spleen Tumors

Indexed keywords

4 AMINOPHENOL; ANILINE; ANILINE DERIVATIVE; HYDROXYLAMINE; NITROSOBENZENE; PARACETAMOL;

BLOOD TOXICITY; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME DAMAGE; DNA DAMAGE; GENE MUTATION; GENOTOXICITY; METHEMOGLOBINEMIA; MUTAGENESIS; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; SPLEEN CANCER; SPLEEN TUMOR;

ANIMALIA;

EID: 30344455011     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440500442384     Document Type: Review

References (330)

1. Abe, S., and Sasaki, M. (1977). Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chemicals. J. Natl. Cancer Inst. 58:1635-1641.
2. Aganović-Mušinović, I., Todić, M., Bečić, F., and Kusturica, J. (2004). Genotoxicity evaluation of paracetamol applying Allium test. Medarh 58:206-209.
3. Allen, B., Zeiger, E., Lawrence, G., Friedman, M., and Shipp, A. (2005). Dose-response modeling of in vivo genotoxicity data for use in risk assessment: Some approaches illustrated by an analysis of acrylamide. Regul. Toxicol. Pharmacol. 41:6-27.
4. Amacher, D.E., Paillet, S.C., Turner, G.N., Ray, V.A., and Salsburg, D.S.(1980). Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation. Mutat. Res. 72:447-474.
5. Amacher, D.E., and Turner, G.N. (1982). Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver. Mutat. Res. 97:49-65.
6. American Cyanamid Company. (1977). Mutagenicity test report on aniline. Unpublished report submitted to U.S. EPA. OTS No. 206052.
7. Ames, B.N., Kammen, H.O., and Yamasaki, E. (1975). Hair dyes are mutagenic: Identification of a variety of mutagenic ingredients. Proc. Nat. Acad. Sci. USA 72:2423-2427.
8. Anantha Reddy, G. (1984). Effects of paracetamol on chromosomes of mouse bone marrow. Caryologia 37:127-132.
9. Anantha Reddy, G., and Subramanyam, S. (1978). Action of paracetamol on dividing cells of Allium cepa. Curr. Sci. 47:20-22.
10. Anantha Reddy, G., and Subramanyam, S. (1981). Response of mitotic cells of Allium cepa.to paracetamol. In: Perspectives in Cytology and Genetics. Eds.: Manna, G.K., Sinha, U., Vol. 3, pp 571-576, Hindasia Pubulishers, New Delhi, India.
11. Anantha Reddy, G., and Subramanyam, S. (1985). Cytogenetic response of meiocytes of Swiss albino mice to paracetamol. Caryologia 38:347-355.
12. Andersson, B., Nordenskjöld, M., Rahimtula, A., and Moldéus, P. (1982). Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products. Mol. Pharmacol. 22:479-485.
13. Andrae, U. (1986). Aniline - Test for the induction of DNA repair in rat hepatocyte primary cultures, Unpublished Report, July, 28th. Gesellschaft für Strahlen- und Umweltforschung, D-8042 Neuherberg.
14. Anonymous. (1988). Final report on the safety assessment of p-aminophenol, m-aminophenol, and o-aminophenol. J. Am. Coll. Toxicol. 7:279-333.
15. Ashby, J., Trueman, R.W., Styles, J., Penman, M.G., and Paton, D. (1981). 4-Chloromethylbi-phenyl (4CMB): A novel mutagen and potential carcinogen. Carcinogenesis 2:33-38.
16. Ashby, J., Lefevre, P.A., and Callander, R.D. (1983). The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I). Mutat. Res. 116:271-279.
17. Ashby, J., Vlachos, D.A., and Tinwell, H. (1991). Activity of aniline in the mouse bone marrow micronucleus assay. Mutat. Res. 263:115-117.
18. Asquith, J.C. for, B.G. Chemie (1985). Mouse micronucleus test on aniline, Toxicol Laboratories Ltd., Lebury, UK, unpublished Report No. 54/8505, October 1985.
19. Assmann, N., Emmrich, M., Kampf, G., and Kaiser, M. (1997). Genotoxic activity of important nitrobenzenes and nitroanilines in the Ames test and their structure-activity relationship. Mutat. Res. 395:139-144.
20. Babayan, E.A., Bagramyan, C.B., Pogosyan, A.S., Egiazaryan, A.R., Saryan, A.V., and Markaryan, K.L. (1987). [Evaluation of the cytogenetic actvity of desmedyfame and phenme-dyfame herbicides and their synthesis products]. Biol. Zh. Armenia. 40:62-67 (in Russian).
21. Bartsch, H., Malaveille, C, Camus, A.-M., Martel-Planche, G., Brun, G., Hautefeuille, A., Sabadie, N., Barbin, A., Kuroki, D., Drevon, C., Piccoli, C., and Montesano, R. (1980). Validation and comparative studies on 180 chemicals with S. thyphimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat. Res. 76:1-50.
22. Belman, S., Troll, W., Teebor, G., and Mukai, F. (1968). The carcinogenic and mutagenic properties of N-hydroxy-aminonaphthalenes. Cancer Res. 28:535-542.
23. Benning, V., Brault, D., Duvinage, C., Thybaud, V., and Melcion, C. (1994). Validation of the in vivo CD1 mouse splenocyte micronucleus test. Mutagenesis 9:199-204.
24. Bergman, K., Müller, L., and Weberg Teigen, S. (1996). The genotoxicity and carcinogenicity of paracetamol: A regulatory (re)view. Mutat. Res. 349:263-288.
25. BG Chemie; Berufsgenossenschaft der chemischen Industrie (1995). Toxikologische Bewertung von p-Aminophenol, Heidelberg.
26. Boido, V., Bennicelli, C., Zanacchi, P., and De Flora, S. (1980). Formation of mutagenic derivatives from nitrite and two primary amines. Toxicol. Lett. 6:379-383.
27. Bomhard, E.M. (2003). High-dose clastogenic activity of aniline in the rat bone marrow and its relationship to the carcinogenicity in the spleen of rats. Arch. Toxicol. 77:291-297.
28. Bomhard, E.M., Brendler-Schwaab, S.Y., Freyberger, A., Herbold, B.A., Leser, K.H., and Richter, M. (2002). O-phenylphenol and ist sodium and potassium salts: A toxicological assessment. Crit. Rev. Toxicol. 32:551-626.
29. Brambilla, G., Carlo, P., Finollo, R., and Ledda, A. (1985). Viscometric detection of liver DNA fragmentation in rats treated with ten aromatic amines. Discrepancies with results provided by the alkaline elution technique. Carcinogenesis 6:1285-1288.
30. Brams, A., Buchet, J.P., Crutzen-Fayt, M.C., de Meester, C., Lauwerys, R., and Léonard, A. (1987). A comparative study, with 40 chemicals, of the efficiency of the Salmonella assay and the SOS chromotest (kit procedure). Toxicol. Lett. 38:123-133.
31. Brennan, R.J., and Schiestl, R.H. (1997). Aniline and its metabolites generate free radicals in yeast. Mutagenesis 12:215-220.
32. Brunborg, G., Holme, J.A., and Hongslo, J.K. (1995). Inhibitory effects of paracetamol on DNA repair in mammalian cells. Mutat. Res. 342:157-170.
33. Burke, D.A., Wedd, D.J., Herriott, D., Bayliss, M.K., Spalding, D.J.M., and Wilcox, P. (1994). Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing. Mutagenesis 9:23-29.
34. Burnett, C.M., Re, T.A., Rodriguez, S., Loehr, R.F., and Dressler, W.E. (1989). The toxicity of p-aminophenol in the Sprague-Dawley rat: Effects on growth, reproduction and foetal development. Fd Chem. Toxic 10:691-698.
35. Bus, J.S., and Popp, J.A. (1987). Perspectives on the mechanism of action of the splenic toxicity of aniline and structurally related compounds. Fd Chem. Toxic 8:619-626.
36. Busser, M.T., and Lutz, W.K. unpublished, cited in Rannug et al., 1995.
37. Butterworth, B.E., Smith-Oliver, T., Earle, L., Loury, D.J., White, R.D., Doolittle, D.J., Working, P.K., Cattley, R.C., Jirtle, R., Michalopoulos, G., and Strom, S. (1989). Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 49:1075-1084.
38. Caldwell, J. (1993). Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: Ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens. Teratogen Carcinogen Mutagen. 13:185-190.
39. Camus, A.-M., Friesen, M., Croisy, A., and Bartsch, H. (1982). Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine. Cancer Res. 42:3201-3208.
40. Cesarone, C.F., Bolognesi, C., and Santi, L. (1982). Evaluation of damage to DNA after in vivo exposure to different classes of chemicals. Arch. Toxicol. Suppl. 5:355-359.
41. Chhabra, R.S., Huff, J.E., Haseman, J.K., Elwell, M.R., and Peters, A.C. (1991). Carcinogenicity of p-chloroaniline in rats and mice. Food Chem. Toxicol. 29:19-124.
42. Chhabra, R.S., Thompson, M., Elwell, M.R., and Gerken, D.K. (1990). Toxicity of p-chloroaniline in rats and mice. Food Chem. Toxicol. 28:717-722.
43. Chételat, A., Albertini, S., and Gocke, E. (1992). Alleged in vivo genotoxicity of paracetamol and green S. Mutat. Res. 298:139-140.
44. Chung, K.-T., Fulk, G.E., and Andrews, A.W. (1981). Mutagenicity testing of some commonly used dyes. Appl. Environ. Microbiol. 42:641-648.
45. Chung, K.-T., Murdock, C.A., Stevens, S.E. Jr., Li, Y.-S., Wei, C.-I., Huang, T.-S., and Chou, M.-W. (1995). Mutagenicity and toxicity studies of p-phenylendiamine and its derivatives. Toxicol. Lett. 81:23-32.
46. Chung, K.-T., Murdock, C.A., Zhou, Y., Stevens, S.E. Jr., Li, Y.-S., Wei C.-I., Fernando, S.Y., and Chou, M.-W. (1996). Effects of the nitro-group on the mutagenicity and toxicity of some benzamines. Environ. Mol. Mutagen. 27:67-74.
47. Ciccoli, L., Ferrali, M., Rossi, V., Signorini, C., Alessandrini, C., and Comporti, M. (1999). Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol. Lett. 110:57-66.
48. +/- mouse lymphoma forward mutation assay. Environ. Mutagen. 6:423 (Abstract).
49. CIIT (Chemical Industry Institute of Toxicology) (1982). A 104-week chronic toxicity study in rats: Aniline hydrochloride. Final report. Research Triangle Park, NC.
50. CIIT (Chemical Industry Institute of Toxicology) (1993). A chronic inhalation toxicity study of nitrobenzene in B6C3F1 mice, Fischer 344 rats and Sprague-Dawley (CD) rats. Final report. Research Triangle Park, NC.
51. CIPC (Chemicals Investigating Promoting Council) (2001). 3-Aminophenol. Toxicity Testing Reports of Environmental Chemicals 8:685-712.
52. Clements, J. (1992). Study to determine the ability of paracetamol to induce mutations at the thymidine kinase (tk) locus in the mouse lymphoma L5178Y cells using a fluctuation assay. Hazleton Microtest Report No. 2TKREUBF.001, cited in Bergman et al., 1996.
53. Cliet, I., Fournier, E., Melcion, C., and Cordier, A. (1989a). In vivo micronucleus tests in mouse. Comparison of the sensitivity of three target organs (bone marrow, liver and testis) to six carcinogens. Environ. Mol. Mutagen. 14(Suppl. 15):39, (Abstract No. 108).
54. Cliet, I., Fournier, E., Melcion, C., and Cordier, A. (1989b). In vivo micronucleus test using mouse hepatocytes. Mutat. Res. 216:321-326.
55. Cliet, I., Melcion, C., and Cordier, A. (1993). Lack of predictivity of bone marrow micronucleus test versus testis micronucleus test: Comparison with four carcinogens. Mutat. Res. 292:105-111.
56. Commoner, B. (1976). Reliability of bacterial mutagenesis techniques to distinguish carcinogenic and noncarcinogenic chemicals. U.S. Department of Commerce, NTIS PB-259 934.
57. Connor, T.H., Cantelli Forti, G., Sitra, P., and Legator, M.S. (1979). Bile as a source of mutagenic metabolites produced in vivo and detected by Salmonella typhimurium. Environ. Mutagen. 1:269-276.
58. Corbett, M.D., Corbett, B.R., Hannothiaux, M.-H., and Quintana, S.J. (1989). Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes. Chem. Res. Toxicol. 2:260-266.
59. Corbett, M.D., Corbett, B.R., Hannothiaux, M.-H., and Quintana, S.J. (1992). The covalent binding of acetaminophen to cellular amino acids as the result of the respiratory burst of neutrophils derived from the HL-60 cell line. Toxicol. Appl. Pharmacol. 113:80-86.
60. CTFA (1982). Submission of data by CTFA. Study No.81/39/0077. Final report. Combined 90-day feeding, teratology and dominant lethal study on m-aminophenol in the Sprague-Dawley rat. Citation from Anonymous (1988).
61. Cunningham, M.L., and Ringrose, P.S. (1983). Benzo(a)pyrene and aniline increase sister chromatid exchanges in cultured rat liver fibroblasts without addition of activating enzymes. Toxicol. Lett. 16:235-239.
62. DeFlora, S. (1981). Study of 106 organic and inorganic compounds in the Salmonella/microsome test. Carcinogenesis 2:283-298.
63. DeFlora, S., Zanacchi, P., Camoirano, A., Bennicelli, C., and Badolati, G.S. (1984a). Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat. Res. 133:161-198.
64. DeFlora, S., Camoirano, A., Zanacchi, P., and Bennicelli, C. (1984b). Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat. Res. 134:159-165.
65. Degawa, M., Shoji, Y., Masuko, K., and Hashimoto, Y. (1979). Mutagenicity of metabolites of carcinogenic aminoazo dyes. Cancer Lett. 8:71-76.
66. Doctor, S.V. (1980). A study of the conversion of selected aromatic amines to mutagens by porcine hepatocyte microsomal fraction and nuclei. Ph. D. thesis, Baylor University.
67. Dugan, A.M. (1994). Salmonella typhimurium as a test system for detecting mutagenic activity of environmental pollutants. Citologija i Genetika 28:37-41 (in Russian).
68. Dunkel, V.C., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortelmans, K., Rosenkranz, H.S., and Simmon, V.F. (1984). Reproducibility of microbial mutagenicity assays: I. Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ. Mutagen. 6(Suppl. 2):1-254.
69. Dunkel, V.C., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortelmans, K., Rosenkranz, H.S., and Simmon, V.F. (1985). Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ. Mutagen. 7(Suppl. 5):1-248.
70. Dunn, T.L., Gardiner, R.A., Seymour, G.J., and Lavin, M.F. (1987). Genotoxicity of analgesic compounds assessed by an in vitro micronucleus assay. Mutat. Res. 189:299-306.
71. Dybing, E., Holme, J.A., Gordon, W.P., Soderlund, E.J., Dahlin, D.C., and Nelson, S.D. (1984). Genotoxicity studies with paracetamol. Mutat. Res. 138:21-32.
72. Eiche, A., Bexell, G., and Sandelin, K. (1990). Genotoxicity of p-aminophenol in somatic and germ line cells of Drosophila melanogaster. Mutat. Res. 240:87-92.
73. Fassina, G., Abbondandolo, A., Mariani, L., Taningher, M., and Parodi, S. (1990). Mutagenicity in V79 cells does not correlate with carcinogenicity in small rodents for 12 aromatic amines. J. Toxicol. Environ. Health 29:109-130.
74. Fiskesjö, G. (1990). Chromosome breaks by paracetamol in a plant test system. International ENEA Conference, Lerici (Abstract), cited in Rannug et al., 1995.
75. Florin, I., Rutberg, R., Curvall, M., and Enzell, C.R. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames test. Toxicology 15:219-232.
76. Fluck, E.R., Poirier, L.A., and Ruelius, H.W. (1976). Evaluation of DNA polymerase-deficient mutant of E. coli for the rapid detection of carcinogens. Chem.-Biol. Interact 15:219-231.
77. Fox, V. (2001). Aniline hydrochloride rat bone marrow micronucleus test. Unpublished report of the Central Toxicology Laboratory, Syngenta, Macclesfield, UK.
78. Fritzenschaf, H., Kohlpoth, M., Rusche, B., and Schiffmann, D. (1993). Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation. Mutat. Res. 319:47-53.
79. Galloway, S.M., Armstrong, M.J., Reuben, C., Colman, S., Brown, B., Cannon, C., Bloom, A.D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B., and Zeiger, E. (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagen. 10(Suppl. 10):1-175.
80. Galloway, S.M., Bean, C.L., Armstrong, M.A., Deasy, D., Kraynak, A., and Bradley, M.O. (1985). False positive in vitro chromosome aberration tests with non-mutagens at high concentrations and osmolalities. Environ. Mutagen. 7(Suppl.):48 (Abstract).
81. Garberg, P., Akerblom, E.-L., and Bolcsfoldi, G. (1988). Evaluation of a genotoxicity test measuring DNA-strand breaks in mouse lymphoma cells by alkaline unwinding and hydroxyapatite elution. Mutat. Res. 203:155-176.
82. Garner, R.C., and Nutman, C.A. (1977). Testing for some azo dyes and their reduction products for mutagenicity using Salmonella typhimurium TA 1538. Mutat. Res. 44:9-19.
83. Gentile, J.M., Gentile, G.J., and Plewa, M.J. (1987). Mutagenicity of selected aniline derivatives to Salmonella following plant activation and mammalian hepatic activation. Mutat. Res. 188:185-196.
84. George, E., Andrews, M., and Westmoreland, C. (1990). Effects of azobenzene and aniline in the rodent bone marrow micronucleus test. Carcinogenesis 11:1551-1556.
85. Giri, A.K., Sai Sivam, S., and Khan, K.A. (1992). Sister-chromatid exchange and chromosome aberrations induced by paracetamol in vivo in bone-marrow cells of mice. Mutat. Res. 278:253-258.
86. Giri, A.K. (1993). The genetic toxicology of paracetamol and aspirin: A review. Mutat. Res. 296:199-210.
87. Goldman, P., Wheeler, L.A., Carter, J.H., Ingelfinger, J.A., and Soderberg, F.B. (1977). Properties of the Ames Salmonella mutants lodged in the gastrointestinal tract of gnotobiotic rats. Am. J. Clin. Nutr. 30:1921-1926.
88. Goldman, P., Carter, J.H., and Wheeler, L.A. (1980). Mutagenesis within the gastrointestinal tract determined by histidine auxotrophs of Salmonella typhimurium. Cancer 45:1068-1072.
89. Goodman, D.G., Ward, J.M., and Reichardt, W.D. (1984). Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine hydrochloride, 4,4′- sulfonyldianiline, or D & C Red No. 9. JNCI 73:265-273.
90. Goodyear Tire & Rubber Company (1980). Mutagenicity evaluation of Aniline. Salmonella typhimurium/microsome bioassay. Laboratory Report No. 80-9-4, unpublished. Submitted to U.S. EPA. OTS No. 205938.
91. Grantham, P.H., Matsushima, T., Mohan, L., Weisburger, E.K., and Weisburger, J.H. (1972). Changes in the metabolism of labelled acetanilide and binding of isotope to serum and liver macromolecules during chronic administration. Xenobiotica 2:551-565.
92. Grossman, S.C., and Jollow, D.J. (1986). Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab. Dispos. 14:689-691.
93. Hamm, T.E. (1984). Ninety-day inhalation study of nitrobenzene in F344 rats, and B6C3F1 mice. Subchronic bioassay, Docket No. 12634, Chemical Industry Institute of Toxicology (CIIT), Research Triangle Park, NC.
94. Hamm, T.E., Phelps, M., Raynor, T.H., and Irons, R.D. (1984). A 90-day inhalation study of nitrobenzene in F-344 rats and B6C3F1 mice. Toxicologist 4:181 (abstract).
95. Hampton, M.J., Floyd, R.A., Janzen, E.G., and Shetty, R.V. (1981). Mutagenicity of free-radical spin-trapping compounds. Mutat. Res. 91:279-283.
96. Hantson, P., de Saint-Georges, L., Mahieu, P., Léonard, E.D., Crutzen-Fayt, M.C., and Léonard, A. (1996). Evaluation of the ability of paracetamol to produce chromosome aberrations in man. Mutat. Res. 368:293-300.
97. Harrison, J.H., and Jollow, D.J. (1987). Contribution of aniline metabolites to aniline-induced methemoglobinemia. Molec. Pharrmacol. 32:432-431.
98. Harper, B.L., Ramanujam V.M.S., Gad-El-Karim, M.M., and Legator, M.S. (1984). The influence of simple aromatics on benzene clastogenicity. Mutat. Res. 128:105-114.
99. Hasegawa, R., Furukawa, F., Toyoda, K., Jang, J.J., Yamashita, K., Sato, S., Takahashi, M., and Hayashi, Y. (1988). Study for tumor-initiating effect of acetaminophen in two-stage liver carcinogenesis of male F344 rats. Carcinogenesis 9:755-759.
100. Haworth, S.R., Lawlor, T.E., Lilja, H.S., Douglas, J.F., Cameron, T., and Dunkel, V.C. (1981). Mutagenicity evaluation of urine collected from rodents treated with either 2-acetylaminofluorene (2AAF), p-rosaniline, 8-hydroxyquinoline or aniline HCl. Environ. Mutagen. 3:379 (Abstract).
101. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W., and Zeiger, E. (1983). Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen. 5(Suppl. 1):3-142.
102. Hayashi. (1981). Effects of harman and norharman on the metabolism of aniline and p-dimethylaminoazobenzene. Jap. J. Hyg. 36:495-505.
103. Hayward, N.K., and Lavin, M.F. (1985). p-Aminophenol induced DNA damage and cytotoxicity enhanced by autoxidation. Life Sci. 36:2039-2046.
104. Hayward, N.K., Lavin, M.F., and Craswell, P.W. (1982). Inhibition of DNA synthesis and alteration to DNA structure by the phenacetin analog p-aminophenol. Biochem. Pharmacol. 31:1425-1429.
105. Hazleton Microtest (1992). Unscheduled DNA synthesis and S-phase synthesis induced by paracetamol in rat liver. Study No. UBF1/1LU, cited in Bergman et al., 1996.
106. Hecht, S.S., El-Bayoumy, K., Tulley, L., and LaVoie, E. (1979). Structure-mutagenicity relationships of N-oxidized derivatives of aniline, o-toluidine, 2′-methyl-4-aminobi-phenyl and 3,2′-dimethyl-4- aminobiphenyl. J. Med. Chem. 22:981-987.
107. Heijtmancik, M.R., Trela, B.A., Kurtz, P.J., Persing, R.L., Ryan, M.J., Yarrington, J.T., and Chhabra, R.S. (2002). Comparative gavage subchronic toxicity studies of o-chloroaniline and m-chloroaniline in F344 rats and B6C3F1 mice. Toxicol. Sci. 69:234-243.
108. Hellmér, L., and Bolcsfoldi, G. (1992a). An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. I. In vitro sensitivity of the bacteria to 61 compounds. Mutat. Res. 272:145-160.
109. Hellmér, L., and Bolcsfoldi, G. (1992b). An evaluation of the E. coli K-12 uvrB/recA DNA repair host-mediated assay. II: In vivo results for 36 compounds tested in the mouse. Mutat. Res. 272:161-173.
110. Hiramoto, K., Kanamitsu, S.-I., Negishi, K., Ikeda, H., and Hayatsu, H. (1995). Induction of DNA recombination by activated 3-amino-1-methyl-5H- pyrido[4,3-b]indole. Jpn. J. Cancer Res. 86:155-159.
111. Ho, C.-H., Clark, B.R., Guerin, M.R., Barkenbus, B.D., Rao, T.K., and Epler, J.L. (1981). Analytical and biological analyses of test materials from the synthetic fuel technologies. IV. Studies of chemical structure-mutagenic activity relationships of aromatic nitrogen compounds relevant to synfuels. Mutat. Res. 85:335-345.
112. Hofer, H., Bornatowicz, N., and Reindl, E. (1983). Analysis of human chromosomes after repeated hair dyeing. Fd Chem. Toxicol. 21:785-789.
113. Holder, J.W. (1999). Nitrobenzene carcinogenicity in animals and human hazard evaluation. Toxicol. Ind. Health 15:445-457.
114. Holme, J.A., and Søderlund, E. (1986). Species differences in cytotoxic and genotoxic effects of phenacetin and paracetamol in primary monolayer cultures of hepatocytes. Mutat. Res. 164:167-175.
115. Holme, J.A., Hongslo, J.K., Bjoernstad, C., Harvison, P.J., and Nelson, S.D. (1988). Toxic effects of paracetamol and related structures in V79 chinese hamster cells. Mutagenesis 3:51-56.
116. Holme, J.A., Smith, C.V., Brunborg, G., Søderlund, E.J., and Hongslo, J.K. (1993). Direct DNA damage in mouse liver after exposure to paracetamol. Mutat. Res. 291:243-244 (Abstract).
117. Hongslo, J.K., Bjørge, C, Schwarze, P.E., Brøgger, A., Mann, G., Thelander, L., and Holme, J.A. (1990). Paracetamol inhibits replicative DNA synthesis and induces sister chromatid exchange and chromosomal aberrations by inhibition of ribonucleotide reductase. Mutagenesis 5:475-480.
118. Hongslo, J.K., Bjørnstad, C., Schwarze, P.E., and Holme, J.A. (1989). Inhibition of replicative DNA synthesis by paracetamol in V79 Chinese hamster cells. Toxic in vitro 3:13-20.
119. Hongslo, J.K., Brøgger, A., Bjørge, C., and Holme, J.A. (1991). Increased frequency of sister-chromatid exchange and chromatid breaks in lymphocytes after treatment of human volunteers with therapeutic doses of paracetamol. Mutat. Res. 261:1-8.
120. Hongslo, J.K., Christensen, T., Brunborg, G., Bjørnstad, C., and Holme, J.A. (1988). Genotoxic effects of paracetamol in V79 Chinese hamster cells. Mutat. Res. 204:333-341.
121. Hongslo, J.K., Smith, C.V., Brunborg, G., Søderlund, E.J., and Holme, J.A. (1994). Genotoxicity of paracetamol in mice and rats. Mutagenesis 9:93-100.
122. Hoshi, M., Morimura, K., Wanibuchi, H., Wei, M., Okochi, E., Ushijama, T., Takaoka, K., and Fukushima, S. (2004). No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a carcinogen. Toxicol. Sci. 81:273-279.
123. Hossack, D.J.N., and Richardson, J.C. (1977). Examination of the potential mutagenicity of hair dye constituents using the micronucleus test. Experientia 33:377-378.
124. IARC. (1982). Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 27, pp. 20-61.
125. IARC (1987). Monographs on the Evaluation of Carcinogenic Risks to Humans. Suppl. 7, pp. 99-100.
126. IARC (1999). Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 73, pp. 401-449.
127. Imamura, A., Kurumi, Y., Danzuka, T., Kodama, M., Kawachi, T., and Nagao, M. (1983). Classification of compounds by cluster analysis of Ames test data. Gann. 74:196-204.
128. Irons, R.D., Gross, E.A., and White, E.L. (1980). Aniline: Evidence for an eneterogastric cycle in the rat. Fd Chem. Toxicol. 18:393-397.
129. Ishidate, M. (Ed) (1983). Chromosomal aberration test in vitro. Realize Inc., Tokyo, p. 31-32.
130. Ishidate, M., Jr., and Odashima, S. (1977). Chromosome tests with 134 compounds on Chinese hamster cells in vitro - a screening for chemical carcinogenesis. Mutat. Res. 48:337-354.
131. Israili, Z.H., Cucinell, S.A., Vaught, J., Davis, E., Lesser, J.M., and Dayton, P.G. (1973). Studies of the metabolism of dapsone in man and experimental animals: Formation of N-hydroxy metabolites. J. Pharmacol. Exp. Therap. 187:138-151.
132. Iwersen-Bergmann, S., and Schmoldt, A. (2000). Acute intoxication with aniline: Detection of acetaminophen as aniline metabolite. Int. J. Legal Med. 113:171-174.
133. Jasiewicz, M.L., and Richardson, J.C. (1987). Absence of mutagenic activity of benorylate, paracetamol and aspirin in the Salmonella microsome test. Mutat. Res. 190:95-100.
134. JETOC, Japan Chemical Industry Ecology-Toxicology & Information Center (2000). Mutagenicity test data of existing chemical substances. Suppl. 2:155.
135. Jones, E., and Fox, V. (2003). Lack of clastogenic activity of aniline hydrochloride in the mouse bone marrow. Mutagenesis 18:283-286.
136. Jung, R., Engelhart, G., Herbold, B., Jäckh, R., and Müller, W. (1992). Collaborative study of mutagenicity with Salmonella typhimurium TA102. Mutat. Res. 278:265-270.
137. Kanaya, N. (1990). Induction of chromosome damage by aniline and its C-hydroxy-lated metabolites in the root cells of Vicia faba. Mutat. Res. 245:311-315.
138. Kanki, K., Nishikawa, A., Masumura, K., Umemura, T., Imazawa, T., Kitamura, Y., Nohmi, T., and Hirose, M. (2005). In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Molec. Carcinogen 42:9-17.
139. Kao, J., Faulkner, J., and Bridges, J.W. (1978). Metabolism of aniline in rats, pigs and sheep. Drug Metab. Dispos. 6:549-555.
140. Karasová, M., Čatár, G., Kieferová, L., and Čižmárik, J. (1984). Effect of intermediate products of synthesis and some potential metabolites of heptacaine chloride on mammalian chromosomes. Bratisl. lek. listy. 82:1423-1429.
141. Kawachi, T., Komatsu, T., Kada, T., Ishidate, M., Sasaki, M., Sugiyama, T., and Tazima, Y. (1980a). Results of recent studies on the relevance of various short-term screening tests in Japan. Appl. Methods Oncol. 3:253-267.
142. Kawachi, T., Yahagi, T., Kada, T., Tazima, Y., Ishidate, M., Sasaki, M., and Sugiyama, T. (1980b). Cooperative programme on short-term assays for carcinogenicity in Japan. IARC (International Agency for Research on Cancer) Scientific Publications No. 27, Lyon, France, pp. 323-330.
143. Khan, M.F., Kaphalia, B.S., and Ansari, G.A.S. (1995). Erythrocyte-aniline interaction leads to their accumulation and iron deposition in rat spleen. J. Toxicol. Environ. Health 44:415-421.
144. Khan, M.F., Boor, P.J., Gu, Y., Alcock, N.M., and Ansari, G.A.S. (1997a). Oxidative stress in the splenotoxicity of aniline. Toxicol. Appl. Pharmacol. 35:22-30.
145. Khan, M.F., Wu, X., Kaphalia, B.S., Boor, P.J., and Ansari, G.A.S. (1997b). Acute hematopoietic toxicity of aniline in rats. Toxicol. Lett. 92:31-37.
146. Khan, M.F., Green, S.M., Ansari, G.A.S., and Boor, P.J. (1998). Phenylhydroxylamine: Role in aniline-associated splenic oxidative stress and induction of subendocardial necrosis. Toxicol. Sci. 42:64-71.
147. Khan, M.F., Wu, X., Alcock, N.M., Boor, P.J., and Ansari, G.A.S. (1999a). Iron exacerbates aniline-assoiated splenic toxicity. J. Toxicol. Environ. Health Part A 57:173-184.
148. Khan, M.F., Wu, X., Boor, P.J., and Ansari, G.A.S. (1999b). Oxidative modification of lipids and proteins in aniline-induced splenic toxicity. Toxicol. Sci. 24:134-140.
149. Khan, M.F., Wu, X., and Ansari, G.A.S. (2000). Contribution of nitrosobenzene to splenic toxicity of aniline. J. Toxicol. Environ. Health, Part A 60:263-273.
150. Khan, M.F., Wu, X., Ansari, G.A.S., and Boor, P.J. (2003a). Malondialdehyde-protein adducts in the spleens of aniline-treated rats: Immunochemical detection and localization. J. Toxicol. Environ. Health, Part A, 66:93-102.
151. Khan, M.F., Wu, X., and Wang, J. (2003b). Up-regulation of transforming growth factor-β1 in the spleen of aniline-treated rats. Toxicol. Appl. Pharmacol. 187:22-28.
152. Kiese, M. (1966). The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation. Pharmacol. Rev. 18:1091-1161.
153. Kiese, M., and Taeger, K. (1976). The fate of phenylhydroxylamine in human red cells. Naunyn-Schmiedebergs Arch. Pharmacol. 292:59-66.
154. King, M.-T., Beikirch, H., Eckhardt, K., Gocke, E., and Wild, D. (1979). Mutagenicity studies with X-ray-contrast media, analgesics, antipyretics, antirheumatics and some other pharmaceutical drugs in bacterial, Drosophila and mammalian test systems. Mutat. Res. 66:33-43.
155. Kirchner, G., and Bayer, U. (1982). Genotoxic activity of the aminophenols as evidenced by the induction of sister chromatid exchanges. Human Toxicol. 1:387-392.
156. Kirkland, D.J., Dresp, J.H., Marshall, R.R., Baumeister, M., Gerloff, C., and Gocke, E. (1992). Normal chromosomal aberration frequencies in peripheral lymphocytes of healthy human volunteers exposed to a maximum daily dose of paracetamol in a double blind trial. Mutat. Res. 279:181-194.
157. Kočišová, J., Rossner, P., Binková, B., Bavorová, H., and Šrám, R.J. (1988). Mutagenicity studies on paracetamol in human volunteers. I. Cytogenetic analysis of peripheral lymphocytes and lipid peroxidation in plasma. Mutat. Res. 209:161-165.
158. Kočišová, J., and Šrám, R.J. (1990). Mutagenicity studies on paracetamol in human volunteers. III. Cytokinesis block micronucleus method. Mutat. Res. 244:27-30.
159. Kuboyama, N., and Fujii, A. (1992). Mutagenicity of analgesics, their derivatives, and anti-inflammatory drugs with S-9 mix of several animal species. J. Nihon Univ. Sch. Dent. 34:183-195.
160. Kusakabe, H., Yamakage, K., Wakuri, S., Sasaki, K., Nakagawa, Y., Watanabe, M., Hayashi, M., Sofuni, T., Ono, H., and Tanaka, N. (2002). Relevance of chemical structure and cytotoxicity to the induction of chromosome aberrations based on the testing results of 98 high production volume industrial chemicals. Mutat. Res. 517:187-198.
161. Lahitová, N., Čižmárik, J., and Ebringer, L. (1982). Effect of heptacaine and of some intermediary products during its synthesis on Salmonella typhimurium and Escherichia coli. Folia. Microbiol. 27:269-271.
162. Lavoie, E., Tulley, L., Fow, E., and Hoffman, D. (1979). Mutagenicity of aminophenyl and nitrophenyl ethers, sulfides and disulfides. Mutat. Res. 67:123-131.
163. Laxminarayana, D., Murthy, D.K., and Subramanyam, S. (1980). Cytogenetical action of paracetamol on meiotic cells of male mice. Cytobios 27:27-34.
164. Levan, A., and Tjio, J.H. (1948). Induction of chromosome fragmentation by phenols. Hereditas 34:453-484.
165. Levi, B.Z., Kuhn, J.C., and Ulitzur, S. (1986). Determination of the activity of 16 hydrazine derivatives in the bioluminescence test for genotoxic agents. Mutat. Res. 173:233-237.
166. Lou, Y.-J., Ying, Y., Wu, F.-W., and Bao, J.-H. (1993). Inductive effects of aspirin, paracetamol and ibuprofen on micronuclei of rat preimplanted blastocysts in vivo. Chin. J. Pharmacol. Toxicol. 7:297-300.
167. Lutz, W.K. (1979). In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res. 65:289-356.
168. Lutz, W.K. (1998). Dose-response relationships in chemical carcinogenesis: Superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. Mutat. Res. 405:117-124.
169. Lyons, C.D., Katz, S.E., and Bartha, R. (1985). Persistence and mutagenic potential of herbicide-derived aniline residues in pond water. Bull. Environ. Contam. Toxicol. 35:696-703.
170. Madle, S., von der Hude, W., Broschinski, L., and Jänig, G.-R. (2000). Threshold effects in genetic toxicity: Perspective of chemical regulation in Germany. Mutat. Res. 464:117-121.
171. Majeska, J.B., and Holden, H.E. (1995). Genotoxic effects of p-aminophenol in Chinese hamster ovary and mouse lymphoma cells: Results of a multiple endpoint test. Environ. Mol. Mutagen. 26:163-170.
172. Mamber, S.W. (1981). Aspects of validation, standardization, and statistical analysis in bacterial genetic toxicology testing. Ph. D. thesis, Rutgers University, New Brunswick, NJ, USA.
173. Mamber, S.W., Bryson, V., and Katz, S.E. (1983). The Escherichia coli WP2/WP100 rec assay for detection of potential chemical carcinogens. Mutat. Res. 119:135-144.
174. Mamber, S.W., Bryson, V., and Katz, S.E. (1984). Evaluation of the Escherichia coli K12 inductest for detection of potential chemical carcinogens. Mutat. Res. 130:141-151.
175. Marques, M.M., Mourato, L.L., Amorim, M.T., Santos, M.A., Melchior, W.B., and Beland, F.A. (1997). Effect of substitution site upon the oxidation potentials of alkylamines, the mutagenicities of N-hydroxylalkylanilines, and the conformations of alkylaniline-DNA adducts. Chem. Res. Toxicol. 10:1266-1274.
176. Marshall, R.R. (1992). Study to evaluate the chromosome damaging potential of paracetamol by its effects on cultured human lymphocytes using an in vitro cytogenetics assay. Hazleton Microtest Report No. IHJREUBF.001 cited in Bergman et al., 1996.
177. Marshall, R.R. (1993). Study to evaluate the potential of paracetamol to induce micronuclei in the bone marrow of Sprague-Dawley rats. Hazleton Microtest Report No. RDMREROC.002 cited in Bergman et al., 1996.
178. Martin, F.L., Cole, K.J., Orme, M.H., Grover, P.L., Phillips, D.H., and Venitt, S. (1999). The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis ('comet') assay in metabolically-competent MCL-5 cells. Mutat. Res. 445:21-43.
179. + parent WP2 uvrA/ pKM101: Detection of 31 oxidative mutagens. Mutat. Res. 467:41-53.
180. Matsuoka, A., Yamazaki, N., Suzuki, T., Hayashi, M., and Sofuni, T. (1993). Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res. 272:223-236.
181. Matsushima, T., Sugimura, T., Nagao, M., Yahagi, T., Shirai, A., and Sawamura, M. (1980). Factors modulating mutagenicity in microbial tests. In: Norpoth, K.H., Garner, R.C. (eds): Short-term test systems for detecting carcinogens, Berlin, pp. 273-285.
182. Matsushima, T., Hayashi, M., Matsuoka, A., Ishidate, M., Jr., Miura, K.F., Shimizi, H., Suzuki, Y., Morimoto, K., Ogura, H., Mure, K., Koshi, K., and Sofuni, T. (1999). Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 14:569-580.
183. Matula, T.I., Vezina, M., and Downie, R. (1984). Mutagenicity of phenazopyridine and its urinary metabolites. Environ. Mutagen. 6:452 (Abstract Gb-18).
184. McCann, J., Choi, E., Yamasaki, E., and Ames, B.N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc. Nat. Acad. Sci. USA 72:5135-5139.
185. McCarroll, N.E., Keech, B.H., and Piper, C.E. (1981a). A microsuspension adaptation of the Bacillus subtilis "rec" assay. Environ. Mutagen. 3:607-616.
186. McCarroll, N.E., Piper, C.E., and Keech, B.H. (1981b). An E. coli microsuspension assay for the detection of DNA damage induced by direct-acting agents and promutagens. Environ. Mutagen. 3:429-444.
187. 1 mice. Cancer Res. 45:174-180.
188. McGregor, D.B., Brown, A.G., Howgate, S., McBride, D., Riach, C., and Caspary, W.J. (1991). Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ. Mol. Mutagen. 17:196-219.
189. McQueen, C.A., Maslansky, C.J., Crescenzi, S.B., and Williams, G.M. (1981). The genotoxicity of 4,4′-methylenebis-2-chloroaniline in rat, mouse, and hamster hepatocytes. Toxicol. Appl. Pharmacol. 58:231-235.
190. Mellert, W., Deckardt, K., Gembardt, C., Zwirner-Baier, I., Jäckh, R., and van Ravenzwaay, B. (2004). Aniline: Early indicators of toxicity in male rats and their relevance to spleen carcinogenicity. Human Exp. Toxicol. 23:379-389.
191. MHW, Japan, Ministry of Health & Welfare, Chemicals Investigation Promoting Council (1997). Toxicity testing reports of environmental chemicals. Vol. 5:443-474.
192. Milam, K.M., and Byard, J.L. (1985). Acetaminophen metabolism, cytotoxicity, and genotoxicity in rat primary hepatocyte cultures. Toxicol. Appl. Pharmacol. 79:342-347.
193. Milburn, G.M. (1998). Aniline: Dominant lethal study in the rat. Unpublished report No. CTL/P/5404. Central Toxicology Laboratory, Alderley Park, Macclesfield, UK.
194. Miltenburger, H.G. (1986). Laboratorium für Mutagenitä tsprüfung (LMP) TH Darmstadt. Unpublished report No. 102. April 3, 1986, submitted to BG Chemie.
195. Mitchell, I.G. (1978). Microbial assays for mutagenicity: A modified liquid culture method compared with the agar plate system for precision and sensitivity. Mutat. Res. 54:1-16.
196. Mitchell, A.D., Rudd, C.J., and Caspary, W.J. (1988). Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at SRI International. Environ. Mol. Mutagen. 12(Suppl. 13):37-101.
197. Mitra, A.B., and Manna, G.K. (1971). Effect of some phenolic compounds on chromosomes of bone marrow cells of mice. Indian J. Med. Res. 59:1442-1447.
198. Miyata, R., Nohmi, T., Yoshikawa, K., and Ishidate, M. (1981). Metabolic activation of p-nitrotoluene and trichloroethylene by rat-liver S9 or mouse-liver S9 fractions in Salmonella typhimurium strains. Eisei Shikensho Hokoku (Tokyo) 99:60-65.
199. Mogili, T., and Vidyavati. (1985). Mutagenic effect of some analgesic and antipyretic drugs on Cladophora crispata (Roth) Kuetz. Phykos 24:88-94.
200. Moreau, P., Bailone, A., and Devoret, R. (1976). Prophage lambda induction in Escheichia coli K12 envA uvrB: A highly sensitive test for potential carcinogens. Proc. Nat. Acad. Soc. Sci. USA 73:3700-3704.
201. Mori, Y., Niwa, T., Hori, T., and Toyoshi, K. (1980). Mutagenicity of 3′-methyl-N,N-dimethyl-4-amino azobenzene metabolites and related compounds. Carcinogenesis 1:121-127.
202. Mori, Y., Totsuka, Y., Fukutome, K., Yoshida, T., Sugimura, T., and Wakabayashi, K. (1996). Formation of DNA adducts by the co-mutagen norharman with aromatic amines. Carcinogenesis 17:1499-1503.
203. Mortelmans, K.E. (1982). Validation and utilization of microbial mutagenesis systems as prescreens for chemical carcinogenesis. SRI Project LSU-5848. Unpublished report, submitted to the National Cancer Institute, March 1982.
204. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. (1986). Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen. 8(Suppl. 7):1-119.
205. Müller, L., Kasper, P., and Madle, S. (1991). Further investigations on the clastogenicity of paracetamol and acetylsalicylic acid in vitro. Mutat. Res. 263:83-92.
206. Müller-Tegethoff, K., Kasper, P., and Müller, L. (1995). Evaluation studies on the in vitro rat hepatocyte micronucleus assay. Mutat. Res. 335:293-307.
207. Muňoz, E.R., and Barnett, B.M. (1998). Evaluation of the genotoxicity of aniline HCl in Drosophila melanogaster. Mutat. Res. 413:15-22.
208. Murín, A., and Čižmárik, J. (1991). Effects of some local anesthetics and intermediary products of their synthesis on chromosomes and mitoses in root tips of Vicio sattiva L. Biológia (Bratislava) 46:203-209.
209. Myhr, B.C., and Caspary, W.J. (1988). Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen. 12(Suppl. 13):103-194.
210. Nagao, M., Yahagi, T., Honda, M., Seino, Y., Matsushima, T., and Sugimura, T. (1977). Demonstration of mutagenicity of aniline and o-toluidine by norharman. Proc. Japan Acad. 53(Ser B):34-37.
211. NCI (National Cancer Institute) (1978). Bioassay of aniline hydrochloride forpossible carcinogenicity. National Institutes of Health, Public Health Service, U.S. Department of Health, Education and Welfare, Bethesda, Maryland, Carcinogenesis Technical Report Series No. 130.
212. Nohmi, T., Ishidate M. Jr., Hiratsuka, A., and Watabe, T. (1985). Mechanism of metabolic activation of the analgetic bucetin to bacterial mutagens by hamster liver microsomes. Chem. Pharm. Bull. 33:2877-2885.
213. Nohmi, T., Yoshikawa, K., Nakadate, M., Miyata, R., and Ishidate, M., Jr. (1984). Mutations in Salmonella typhimurium and inactivation of Bacillus subtilis transforming DNA induced by phenylhydroxylamine derivatives. Mutat. Res. 136:159-168.
214. Nordenskjöld, M., and Moldéus, P. (1983). Induction of DNA-strand breaks in cultured human fibroblasts by reactive metabolites. Ann. New York Acad. Sci. 407:460-462.
215. NTP (1983). National Toxicology Program, Department of Health and Human Services, NTP-82-119.
216. 1 mice (feed studies). Technical Report Series No. 394.
217. 1 mice (inhalation studies). Technical Report Series No. 484.
218. +/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res. 125:291-306.
219. +/- mouse lymphoma assay. Environ. Mol. Mutagen. 27:75-78.
220. Oberly, T.J., Rexroat, M.A., Bewsey, B.J., Richardson, K.K., and Michaelis, K.C. (1990). An evaluation of the CHO/HGPRT mutation assay involving suspension cultures and soft agar cloning: Results for 33 chemicals. Environ. Mol. Mutagen. 16:260-271.
221. +/- mutation assays using suspension treatment and soft agar cloning: Results for 10 chemicals. Cell Biol. Toxicol. 9:243-257.
222. Oberly, T.J., Huffman, D.M., Scheuring, J.C., and Garriott, M.L. (1993b). An evaluation of chromosomal mutagens in the AS52/XPRT mutation assay utilizing suspension culture and soft agar cloning. Mutat. Res. 319:179-187.
223. Oda, Y., Yamazaki, H., Watanabe, M., Nohmi, T., and Shimada, T. (1995). Development of high sensitive umu test system: Rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity. Mutat. Res. 334:145-156.
224. Ogawa, S., Hirayama, T., Fujioka, Y., Ozasa, S., Tokuda, M., Hirai, K., and Fukui, S. (1987). Mutagenicity modulating effect of quercetin on aromatic amines and acetamides. Mutat. Res. 192:37-46.
225. Ohkuma, Y., and Kawanishi, S. (1999). Oxidative DNA damage by a metabolite of carcinnogenic and reproductive toxic nitrobenzene in the presence of NADH and Cu(II). Biochem. Biophys. Res. Commun. 257:555-560.
226. Oldham, J.W., Preston, R.F., and Paulson, J.D. (1986). Mutagenicity testing of selected analgesics in Ames Salmonella strains. J. Appl. Toxicol. 6:237-243.
227. Osano, O., Admiraal, W., Klamer, H.J.C., Pastor, D., and Bleeker, E.A.J. (2002). Comparative toxic and genotoxic effects of chloroacetanilides, formamidines and their degradation products on Vibrio fischeri and Chironomus riparius. Environ. Pollution 119:195-202.
228. + reversion in E. coli. In: Gorrod, J.W. (Ed) Biological Oxidation of Nitrogen, Proc 2nd Int Symp., pp. 375-382.
229. Pai, V., Bloomfield, S.F., and Gorrod, J.W. (1985). Mutagenicity of N-hydroxylamines and N-hydroxycarbamates towards strains of Escherichia coli and Salmonella typhimurium. Mutat. Res. 151:201-207.
230. Parodi, S., Taningher, M., Russo, P., Pala, M., Tamaro, M., and Monti-Bragadin, C. (1981). DNA-damaging activity in vivo and bacterial mutagenicity of sixteen aromatic amines and azo-derivatives, as related quantitatively to their carcinogenicity. Carcinogenesis 2:1317-1326.
231. Parodi, S., Taningher, M., Boero, P., and Santi, L. (1982a). Quantitative correlations amongst alkaline DNA fragmentation, DNA covalent binding, mutagenicity in the Ames test and carcinogenicity, for 21 compounds. Mutat. Res. 93:1-24.
232. Parodi, S., Pala, M., Russo, P., Zunino, A., Balbi, C., Albini, A., Valerio, F., Cimberle, M.R., and Santi, L. (1982b). DNA damage in liver, kidney, bone marrow, and spleen of rats and mice treated with commercial and purified aniline as determined by alkaline elution assay and sister chromatid exchange induction. Cancer Res. 42:2277-2283.
233. Parodi, S., Zunino, A., Ottaggio, L., DeFerrari, M., and Santi, L. (1983). Lack of correlation between the capability of inducing sister-chromatid exchanges in vivo and carcinogenic potency, for 16 aromatic amines and azo derivatives. Mutat. Res. 108:225-238.
234. Patierno, S.R., and Landolph, J.R. (1987). Genotoxicity of aspirin, phenacetin and acetaminophen in C3H/10T1/2 mouse embryo cells. Environ. Mutagen. 9(Suppl 8):84 (Abstract).
235. Patierno, S.R., Lehman, N.L., Henderson, B.E., and Landolph, J.R. (1989). Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells. Cancer Res. 49:1038-1044.
236. Pauluhn, J. (2004). Subacute inhalation toxicology of aniline in rats: Analysis of time-dependence and concentration-dependence of hematotoxic and splenic effects. Toxicol. Sci. 81:198-215.
237. Pauluhn, J., and Mohr, U. (2001). Inhalation toxicity of 4-ethoxyaniline (p-phenetidine): Critical analysis of results of subacute inhalation exposure studies in rats Inhal. Toxicol. 13:993-1013.
238. Prasad, I. (1970). Mutagenic effects of the herbicide 3′,4′-dichloropropionanilide and its degradation products. Canad J. Microbiol. 16:369-372.
239. Probst, G.S., McMahon, R.E., Hill, L.E., Thompson, C.Z., Epp, J.K., and Neal, S.B. (1981). Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures: A comparison with bacterial mutagenicity using 218 compounds. Environ. Mutagen. 3:11-32.
240. Purchase, I.F.H., Longstaff, E., Ashby, J., Styles, J.A., Anderson, D., Lefevre, P.A., and Westwood, F.R. (1978). An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Appendix II. Anderson, D., Styles, J.A.: The bacterial mutation test. Brit. J. Cancer 37:873-959.
241. Rahimtula, A., Moldeus, P., Andersson, B., and Nordenskjöld, M. (1982). Prostaglandin synthetase catalyzed DNA strand breaks by aromatic amines. In: Prostaglandins and Cancer: First International Conference, Alan R. Liss, Inc., New York, pp. 159-162.
242. Ramel, C., and Magnusson, J. (1992). Modulation of genotoxicity in Drosophila. Mutat. Res. 267:221-227.
243. Rannug, U., Holme, J.A., Hongslo, J.K., and Srám, R. (1995). An evaluation of the genetic toxicity of paracetamol. Mutat. Res. 327:179-200.
244. Rashid, K.A., Arjmand, M., Sandermann, H., and Mumma, R.O. (1987). Mutagenicity of chloroaniline/lignin metabolites in the Salmonella/microsome assay. J. Environ. Sci. Health B22:721-729.
245. Ress, N.B., Witt, K.L., Xu, J., Haseman, J.K., and Bucher, J.R. (2002). Micronucleus induction in mice exposed to diazoaminobenzene or its metabolites, benzene and aniline: Implications for diazoaminobenzene carcinogenicity. Mutat. Res. 521:201-208.
246. Roberts, J.J., and Warwick, G.P. (1966). The covalent binding of metabolites of dimethylaminoazobenzene, β-naphthylamine and aniline to nucleic acids in vivo. Int. J. Cancer 1:179-196.
247. Rogers, L.K., Moorthy, B., and Smith, C.V. (1997). Acetaminophen binds to mouse hepatic and renal DNA at human therapeutic doses. Chem. Res. Toxicol. 10:470-476.
248. Rosenkranz, H.S., and Poirier, A. (1979). Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in mirobial systems. J. Natl. Cancer Inst. 62:873-892.
249. Russo, P., Vecchio, D., Balbi, C., Parodi, S., and Santi, L. (1981). Danno al DNA trattamento "in vivo" con alcune ammine aromatiche: 2,4-diamminotoluene, 4-amminoben-zene (anilina) e paradimethylamminobenzene (giallo burro). Boll Soc. It Biol. Sper. 57:131-137.
250. Sakagami, Y., Yokoyama, H., Ose, Y., and Sato, T. (1986). Screening test for carcinogenicity of chlorhexidine digluconate and its metabolites. J. Health Sci. [Eisei Kagaku] 32:171-175.
251. Sakagami, Y., Yamazaki, H., Ogasawara, N., Yokoyama, H., Ose, Y., and Sato, T. (1988). The evaluation of genotoxic activities of disinfectants and their metabolites by umr test. Mutat. Res. 209:155-160.
252. Sasaki, M. (1986). Enhancing effect of acetaminophen on mutagenesis. In: Genetic Toxicology of Environmental Chemicals, Pt. A: Basic Principles and Mechanisms of Action, Alan R. Liss, Inc. pp. 365-372.
253. Sasaki, Y.F., Fujikawa, K., Ishida, K., Kawamura, N., Nishikawa, Y., Ohta, S., Satoh, M., Madarame, H., Ueno, S., Susa, N., Matsusaka, N., and Tsuda, S. (1999). The alkaline single cell gel electrophoresis assay with mouse multiple organs: Results with 30 aromatic amines evaluated by the IARC and U.S. NTP. Mutat. Res. 440:1-18.
254. Sasaki, M., Sugimura, K., Yoshida, M.A., and Abe, S. (1980). Cytogenetic effects of 60 chemicals on cultured human and Chinese hamster cells. La Kromosomo II-20:574-584.
255. Sasaki, M., Yoshida, S., and Hiraga, K. (1983). Additional effect of acetaminophen on the mutagenicity and clastogenicity of N-methyl-N′-nitro- N-nitrosoguanidine in cultured Chinese hamster CHO-K1 cells. Mutat. Res. 122:367-372.
256. Sawada, M., Matsuoka, A., Nohmi, T., Sofuni, T., and Ishidate, M. Jr. (1985). Mutagenicity tests on phenacetin-related compounds in cultured mammalian cells. Mutat. Res. 147:273 (Abstract).
257. Sawamura, M., Matsushima, T., and Sugimura, T. (1978). Utility of hamster S-9 mix: Mutagenicity of phenacetin and its analogs. Proceedings of 37th Annual Meeting of Japanese Cancer Association p43 (Abstract).
258. Schiestl, R.H. (1989). Nonmutagenic carcinogens induce interchromosomal recombination in yeast. Nature 337:285-288.
259. Schiestl, R.H., Gietz, R.D., Mehta, R.D., and Hastings, P.J. (1989). Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis 10:1445-1455.
260. Schweizer, H. (1981). Die Induktion sekundärer Chromosomenaberrationen durch m-Aminophenol in menschlichen Zellkulturen unter besonderer Berücksichtigung der spezifischen Reaktion verschiedener Chromosomenregionen. Dissertation Erlangen-Nürnberg.
261. Sekihashi, K., Yamamoto, A., Matsumura, Y., Ueno, S., Watanabe-Akanuma, M., Kassie, F., Knasmüller, S., Tsuda, S., and Sasaki, Y.F. (2002). Comparative investigation of multiple organs of mice and rats in the Comet assay. Mutat. Res. 517:53-75.
262. Severin, E., and Beleuta, A. (1995). Induction of chromosome aberrations in vivo in bone-marrow cells of mice by paracetamol. Morphol. Embryol. 41:117-120.
263. Shahin, M.M. (1989). Studies on the mutagenicity of aniline in association with norharman in the Salmonella/mammalian microsome assay. Int. J. Cosm. Sci. 11:129-140.
264. 2+-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol. Appl. Pharmacol. 112:32-40.
265. Shimane, Y. (1985). Mutagenicity of acetaminophen on Chinese hamster V79 cells. Shigaku 72:1175-1187.
266. Shimazu, H., Shiraishi, N., Akematsu, T., Ueda, N., and Sugiyama, T. (1976). Carcinogenicity screening tests on induction of chromosomal aberrations in rat bone marrow cells in vivo. Mutat. Res. 38:347 (Abstract).
267. Sicardi, S.M., Martiarena, J.L., and Iglesias, M.T. (1987). Acción clastogénica in vivo de fenacetina y paracetamol. Acta. Farm Bonaerense 6:71-75.
268. Sicardi, S.M., Martiarena, J.L., and Iglesias, M.T. (1991). Mutagenic and analgesic activities of aniline derivatives. J. Pharmac. Sci. 80:761-764.
269. Siesky, A.M., Kamendulis, L.M., and Klaunig, J.E. (2002). Hepatic effects of 2-butoxyethanol in rodents. Toxicol. Sci. 70:252-260.
270. Simkó, M., Kriehuber, R., and Lange, S. (1998). Micronucleus formation in human amnion cells after exposure to 50 Hz MF applied horizontally and vertically. Mutat. Res. 418:101-111.
271. Simmon, V.F. (1979a). In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J. Natl. Cancer Inst. 62:893-899.
272. Simmon, V.F. (1979b). In vitro assays for recombinogenic activity of chemical carcinogens and related compounds with Saccharomyces cerevisiae D3. J. Natl. Cancer Inst. 62:901-909.
273. Smith, C.V., Mitchell, J.R., and Horning, E.C. (1978). Covalent binding of reactive metabolites of acetaminophen and furosemide to hepatic DNA, RNA, and protein in vivo. The Pharmacologist 20:258 (Abstract).
274. Šrám, R.J., Kočišová, J., Rössner, P., Binková, B., Topinka, J., and Bavorová, H. (1990). Mutagenic activity of paracetamol. A study conducted on human volunteers. Czechos Med. 13:114-123.
275. Sugimura, T., Sato, S., Nagao, M., Yahagi, T., Matsushima, T., Seino, Y., Takeuchi, M., and Kawachi, T. (1976). Overlapping of carcinogens and mutagens. In: Magee, P.N. et al. (Eds): Fundamentals in Cancer Prevention. University Park Press, Baltimore, Tokyo, pp. 191-215.
276. Sugimura, T., and Nagao, M. (1981). Carcinogenic, mutagenic, and comutagenic aromatic amines in human foods. Natl. Cancer Inst. Monogr. 58:27-33.
277. Sugimura, T., Nagao, M., and Wakabayashi, K. (1982). Metabolic aspects of the comutagenic action of norharman. Adv. Exp. Med. Biol. 136B: 1011-1025.
278. Sunakawa, T., Inoue, K., and Okamoto, K. (1981). Studies on the mutagenicity of surfactants. Mutagenicity of surfactants following activation with various liver homogenates (S-9) and mutagenicity in the presence of norharman. J. Health Sci., [Eisei Kagaku] 27:204-211.
279. Suzuki, J., Takahashi, N., Kobayashi, Y., Miyamae, R., Ohsawa, M., and Suzuki, J. (1987). Dependence on Salmonella typhimurium enzymes of mutagenicities of nitrobenzene and its derivatives in the presence of rat-liver S9 and norharman. Mutat. Res. 178:187-193.
280. Swenberg, J.A., Petzold, G.L., and Harbach, P.R. (1976). In vitro DNA damage/alkaline elution assay for predicting carcinogenic potential. Biochem. Biophys. Res. Commun. 72:732-738.
281. Swenberg, J.A. (1981). Utilization of the alkaline elution assay as a short-term test for chemical carcinogens. In: Stich, H.F., San, R.H.C (eds) Short-term Tests for Chemical Carcinogens, New York, pp. 48-48.
282. Takehisa, S., and Kanaya, N. (1982). SCE induction in human lymphocytes by combined treatment with aniline and norharman. Mutat. Res. 101:165-172.
283. Takehisa, S., Kanaya, N., and Rieger, R. (1988). Promutagen activation by Vicia faba: An assay based on the induction of sister-chromatid exchanges in Chinese hamster ovary cells. Mutat. Res. 197:195-205.
284. Tamura, T., Fujii, A., and Kuboyama, N. (1980). Pharmacological studies on the mutagenicity: I. Analgesics and inflammatory drugs and their derivatives. Jap. J. Pharmacol. 30(Suppl):238P (Abstract).
285. Tanaka, K.-I., Marui, S., and Mii, T. (1980). Mutagenicity of extracts of urine from rats treated with aromatic amines. Mutat. Res. 79:173-176.
286. Tanooka, H. (1977). Development and applications of Bacillus subtilis test systems for mutagens, involving DNA-repair deficiency and suppressible auxotrophic mutations. Mutat. Res. 42:19-32.
287. Tazima, Y. (1980). Chemical mutagenesis in the silkworm. In: de Serres, F.J., Hollander, A., eds. Chemical Mutagens, Vol 6, New York, Plenum Press, pp. 203-238.
288. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicology assays. Science 236:933-941.
289. Thomas, H. (1995a). Paracetamol: 30 hours oral gavage toxicity and micronucleus study in male and female Tif:RAIf rats. Ciba-Geigy 94/13 (Test No. 940006), cited in Bergman et al., 1996.
290. Thomas, H. (1995b). Paracetamol: Assessment of diagnostic biochemical markers for toxicity (time profile) in male Tif:RAIf rats following single and repeated oral gavage administration. Ciba-Geigy 94/14 (Test No. 940006), cited in Bergman et al., 1996.
291. Thompson, C.Z., Hill, L.E., Epp, J.K., and Probst, G.S. (1983). The induction of bacterial mutation and hepatocyte unscheduled DNA synthesis by monosubstituted anilines. Environ. Mutagen. 5:803-811.
292. Tohda, H., Tada, M., Sugawara, R., and Oikawa, A. (1983). Actions of amino-β-carbolines on induction of sister-chromatid exchanges. Mutat. Res. 116:137-147.
293. Topham, J.C. (1980a). Do induced sperm-head abnormalities in mice specifically identify mammalian mutagens rather than carcinogens? Mutat. Res. 74:379-387.
294. Topham, J.C. (1980b). The detection of carcinogen-induced sperm head abnormalities in mice. Mutat. Res. 69:149-155.
295. Topinka, J., Šrám, R.J., Širinjan, G., Kočišová, J., Binková, B., and Fojtí ková, I. (1989). Mutagenicity studies of paracetamol in human volunteers II. Unscheduled DNA synthesis and micronucleus test. Mutat. Res. 227:147-152.
296. Travlos, G.S., Mahler, J., Ragan, H.A., Chou, B.J., and Bucher, J.R. (1996). Thirteen-week inhalation toxicity of 2- and 4-chloronitrobenzene in F344/N rats and B6C3F1 mice. Fund Appl. Toxicol. 30:75-92.
297. Tsuruzaki, T., Watanabe, G., and Yamamoto, M. (1982). The effects of aspirin and acetaminophen during pregnancy on chromosomal structure in rat fetuses. Jpn. J. Hyg. 37:787-796.
298. Turanitz, K., Kovac, R., Tuschl, H., and Pavlicek, E. (1983). Investigation on the effect of repeated hair dyeing on sister chromatid exchanges. Fd Chem. Toxicol. 21:791-793.
299. Ulitzur, S. (1986). Bioluminescence test for genotoxic agents. Methods Enzymol. 133:264-274.
300. Ulitzur, S., Weiser, I., Levi, B.Z., and Barak, M. (1984). Determination of 100 chemicals by the improved bioluminescence test for mutagenic agents. In: Analytical Applications of Bioluminescence and Chemiluminescence. Eds.: Kricka, L.J., Stanley, P.E., Thorpe, G.H.G, Whitehead, T.P. Academic Press, London, 533-536.
301. U.S. EPA (1985). Health and environmental profile of aminophenols. NTIS PB88-173612.
302. Vlachos, D.A. (1989). Mouse bone marrow micronucleus assay of Aniline. Haskell Lab. Report No. DuPont HLR 263-89 for the Aniline Assoc., June 28, 1989. Unpublished report.
303. Vogel, E.W., and Nivard, M.J. (1993). Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Mutagenesis 8:57-81.
304. Von der Hude, W., Behm, C., Guertler, R., and Basler, A. (1988). Evaluation of the SOS chromotest. Mutat. Res. 203:81-94.
305. Wangenheim, J., and Bolcsfoldi, G. (1988). Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis 3:193-205.
306. Watanabe, M. (1982). The cytogenetic effects of aspirin and acetaminophen on in vitro human lymphocytes. Jpn. J. Hyg. 37:673-685.
307. Watanabe, T., Kawata, A., and Koyanagi, T. (1980). Mutagenicity of hair dyes. Influence of couplers on mutagenicity of primary intermediates and couplers. J. Soc. Cosmet. Chem., Japan 14:20-25.
308. Watanabe, T., Kusumoto, M., Ishihara, M., Okumura, H., Takase, M., Wakisaka, H., and Hirayama, T. (1991). The modulating effect of hair dye components on the formation of mutagenic products from m-phenylenediamine with hydrogen peroxide. Eisei Kagaku 37:512-521.
309. Weinberger, M.A., Albert, R.H., and Montgomery, S.M. (1985). Splenotoxicity associated with splenic sarcomas in rats fed high doses of D & C Red No. 9 or aniline hydrochloride. JNCI 75:681-687.
310. Westmoreland, C., and Gatehouse, D.G. (1991). Effects of aniline hydrochloride in the mouse bone marrow micronucleus test after oral administration. Carcinogenesis 12:1057-1059.
311. Wheeler, L.A., Carter, J.H., Soderberg, F.B., and Goldman, P. (1975). Association of Salmonella mutants with germfree rats: Site-specific model to detect carcinogens as mutagens. Proc. Nat. Acad. Sci. USA 72:4607-4611.
312. Wild, D. (2002). Personal communication to EMB.
313. Wild, D., Eckhardt, K., Gocke, E., and King, M.T. (1980). Comparative results of short-term in vitro and in vivo mutagenicity tests obtained with selectec environmental chemicals. In: Short-term Test Systems for Detecting Carcinogens. Eds.: Norpoth, K.H., Garner, R.C., Springer-Verlag, Berlin:170-179.
314. Wild, D., King, M.T., Eckhardt, K., and Gocke, E. (1981). Mutagenic activity of aminophenols and diphenols and relations with chemical structure. Mutat. Res. 85:456 (Abstract).
315. Williams, G.M. (1977). The detection of chemical carcinogens by unscheduled DNA synthesis in rat primary cell cultures. Cancer Res. 37:1845-1851.
316. Williams, G.M. (1980a). DNA repair and mutagenesis in liver cultures as indicators in chemical carcinogen screening. Adv. Mod. Environ. Toxicol. 1:2773-296.
317. Williams, G.M. (1980b). The detection of chemical mutagens/carcinogns by DNA repair and mutagenesis in liver cultures. In: de Serres FJ, Hollander, A., eds. Chemical Mutagens, Vol 6, New York, Plenum Press, pp. 61-79.
318. Williams, G., Mori, H., and McQueen, C.A. (1989). Structure-activity relationships in the rat hepatocyte DNA-repair test for 300 chemicals. Mutat. Res. 221:263-286.
319. Wilmer, J.L., Kligerman, A.D., and Erexson, G.L. (1981). Sister chromatid exchange induction and cell cycle inhibition by aniline and its metabolites in human fibroblasts. Environ. Mutagen. 3:627-638.
320. Wilmer, J.L., Erexson, G.L., and Kligerman, A.D. (1984). The effect of erythrocytes and hemoglobin on sister chromatid exchange induction in cultured human lymphocytes exposed to aniline HCl. Basic Life Sci. 293:561-567.
321. Wirth, P.J., Dybing, E., von Bahr, C., and Thorgeirsson, S.S. (1980). Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: Metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man. Molec. Pharmacol. 18:117-127.
322. 1 mice from short-term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program. Environ. Mol. Mutagen. 36:163-194.
323. Yamada, K., Shirahata, S., Murakami, H., Nishiyama, K., Shinohara, K., and Omura, H. (1985). DNA breakage by phenyl compounds. Agric. Biol. Chem. 49:1423-1428.
324. Ying, Y., and Lou, Y. (1993). Effects of preimplantation treatment with aspirin and acetaminophen on blastocyst and fetus in rats. Acta. Pharmacol. Sinica. 14:369-372.
325. Yoon, J.S., Mason, J.M., Valencia, R., Woodruff, R.C., and Zimmering, S. (1985). Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the National Toxicology Program. Environ. Mutagen. 7:349-367.
326. Yoshida, S., Nawai, S., and Hiraga, K. (1980). Cytogenetic studies of acetaminophen and its related compounds. Ann. Rep. Tokyo Metr. Res. Lab PH 31-2:102-108.
327. Yoshikawa, K., Uchino, H., and Kurata, H. (1976). Studies on the mutagenicity of hair dye. Eisei Shikensho Hokoku 94:28-32.
328. Yoshikawa, K., Uchino, H., and Kurata, H. (1978). Mutagenicity of benzene derivatives in Salmonella typhimurium. Mutat. Res. 54:262-263.
329. Yoshimi, N., Sugie, S., Iwata, H., Niwa, K., Mori, H., Hashida, C., and Shimizu, H. (1988). The genotoxicity of a variety of aniline derivatives in a DNA repair test with primary cultured rat hepatocytes. Mutat. Res. 206:183-191.
330. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. (1988). Salmonella mutagenicity tests: IV Results from the testing of 300 chemicals. Environ. Molec. Mutagen. 11(Suppl. 12):1-158.